Please provide your email address to receive an email when new articles are posted on . In statin-intolerant patients, inflammation risk contributed more to death and CV events than cholesterol risk.

Please provide your email address to receive an email when new articles are posted on . In patients at high cardiovascular risk already taking statin therapy, level of inflammation better predicted ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense and respond to danger. However, for people with risks for heart disease, ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...

But cardiovascular event rates in all three trials approached 10 percent at five years. In all three trials, blood levels of high-sensitivity C-reactive protein (hs-CRP, a measure of vascular ...

Inflammation plays a central role in the initiation, progression and resolution of cardiovascular events, from the formation of atherosclerotic plaques to the healing phase after myocardial infarction ...

New evidence released today from a study of 31,245 patients already taking statin therapy indicates that inflammation may be a more powerful predictor of risk of future cardiovascular events - such as ...

New research is shedding light on surprising ways to reduce chronic inflammation—including suggestions as simple as flossing your teeth. From infrared saunas to meditation, there are several steps you ...

RCSI University of Medicine and Health SciencesMar 10 2025 New research from RCSI University of Medicine and Health Sciences has found that white blood cells which ‘remember’ past inflammation events ...

Severe airway inflammation impairs the ability of mice to learn when a dangerous situation is no longer a threat, suggesting that the lungs influence emotions and behaviour. This lung-brain connection ...

This randomized controlled, double blinded, parallel design, single site trial adhered to Consolidated Standards of Reporting Trials (CONSORT). The study was approved by the University of California, ...

Immunoglobulin G4 (IgG4) fights viruses and bacteria. However, sometimes it targets the body itself. "This then leads to inflammation, the healing of which the body is unable to keep under control," ...